Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Feb. 27 - April 28, 2004 May 3, 2004
Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Feb. 20 - April 21, 2004# April 26, 2004
Biotech-Big Pharma Collaborations: Modified And Terminated Agreements, Feb. 20 - April 21, 2004# April 26, 2004
Visionary Eyetech Saw Aptamers' Value, Turned Macugen Into Gold April 26, 2004 By Randy Osborne Eyetech Pharmaceuticals Inc.'s CEO David Guyer typically is humble when he talks about the company's landmark potential $750 million deal in late 2002 with Pfizer Inc. for Macugen, the in-licensed aptamer for age-related macular degeneration.Read More
RSS